…for use that are expected to be safe, immunogenic, efficacious, and of suitable quality for individuals Recommend vaccination strategies to promote health, prevent and control infectious diseases, and prepare for…
https://youtu.be/42cAjGuFaIw The National Collaborating Centre for Infectious Diseases presents: The Public Health Agency of Canada (PHAC) COVID-19 Vaccines Webinar for Health Care Providers to inform health care and vaccine providers…
…supports signal detection, assessment, investigation and response; involves collaboration among domestic and international partners and industry Objectives: • Establish, maintain, and/or enhance coordinated and collaborative post-market vaccine safety monitoring by…
…partners [3-5]. Notifi ed part- ners, both those who tested HIV-positive and those who tested HIV-negative, were found to signifi cantly decrease their mean number of sex partners and increase…
…(WHO) and peer reviewed literature. This disease debrief was prepared by Signy Baragar. Questions, comments, and suggestions regarding this disease brief are most welcome and can be sent to nccid@manitoba.ca….
…for guiding the design and evaluation of effective population based programs and strategies. GIS can summarize vast amounts of tabular data into compelling visual maps that can provide powerful insights…
Key Points: Prior to the 2009 influenza pandemic, influenza was diagnosed in many laboratories by enzyme-linked immunosorbent assay (ELISA) or immunochromatographic tests (rapid influenza diagnostic tests; RIDT), immunofluorescence microscopy (direct…
…H Connect Care’s Best Practice Advisory for Syphilis Insights for public health responses to congenital syphilis testing and prevention What’s Inside… Infectious syphilis has risen significantly in Alberta from a…
…EV-D68 cases, recovery has occurred within a few days of supportive care, including a significant proportion requiring intensive care and assisted ventilation. Acute Flaccid Paralysis Since September, 2014, the CDC…
…significantly from previously circulating strains [2, 3]. The WHO GISN enables WHO to recommend twice annually the composition of the influenza vaccine for the subsequent influenza season in the northern…
…specific point in time for a particular population, how many people have previously been exposed to COVID-19? The idea would be to design your serosurvey as such that you could…
